Mosfellsbær, Iceland

Ellen Ruth Ingimundardottir

This inventor holds 1 USPTO granted patent. Top assignee: Lyfjathroun Hf.. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ellen Ruth Ingimundardottir. Retrieved from https://idiyas.com/inventor/ellen-ruth-ingimundardottir

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 42(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Ellen Ruth Ingimundardottir

Introduction

Ellen Ruth Ingimundardottir is a notable inventor based in Mosfellsbaer, Iceland. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that enhance drug absorption. Her work is characterized by a focus on improving therapeutic delivery methods.

Latest Patents

Ellen holds 1 patent for her invention titled "Absorption Promoting Agent." This patent relates to pharmaceutical compositions that include polyoxyethylene glycol and fatty acid mono- and diglyceride esters as absorption promoting agents. These compositions are particularly suitable for mucosal administration, such as intranasal delivery, which can enhance the effectiveness of various therapeutic substances.

Career Highlights

Throughout her career, Ellen has demonstrated a commitment to advancing pharmaceutical science. Her innovative approach to drug formulation has the potential to improve patient outcomes by facilitating more effective drug absorption.

Collaborations

Ellen has collaborated with esteemed colleagues in her field, including Sveinbjorn Gizurarson and Sigridur Olafsdottir. These partnerships have contributed to the development of her groundbreaking work in pharmaceutical compositions.

Conclusion

Ellen Ruth Ingimundardottir's contributions to the field of pharmaceuticals exemplify the impact of innovative thinking in enhancing drug delivery systems. Her work continues to inspire advancements in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…